Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

cabot corp. - CBT

CBT

Close Chg Chg %
80.39 -1.36 -1.69%

Open Market

79.03

-1.36 (1.69%)

Volume: 136.47K

Last Updated:

Sep 9, 2026, 1:08 PM EDT

Trade Now

Company Overview: cabot corp. - CBT

CBT Key Data

Open

$80.11

 Day Range

78.59 - 80.11

52 Week Range

58.33 - 94.53

 Market Cap

$4.21B

Shares Outstanding

51.63M

 Public Float

50.72M

Beta

0.83

 Rev. Per Employee

N/A

P/E Ratio

22.97

 EPS

$3.56

Yield

229.71%

 Dividend

$0.47

EX-DIVIDEND DATE

Aug 28, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

338.61K

  

CBT Performance

1 Week
 
 -1.42%
 
1 Month
 
 -8.33%
 
3 Months
 
 -8.36%
 
1 Year
 
 1.67%
 
5 Years
 
 58.74%
 

CBT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About cabot corp. - CBT

Cabot Corp. is a global specialty chemicals and performance materials company. The firm's products include reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants, and aerogel. It operates through the Reinforcement Materials and Performance Chemicals segments. The Reinforcement Materials segment involves the rubber blacks and elastomer composites product lines. The Performance Chemicals segment refers to specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. The company was founded by Godfrey Lowell Cabot in 1882 and is headquartered in Boston, MA.

CBT At a Glance

Cabot Corp.
2 Seaport Lane
Boston, Massachusetts 02210-2019
Phone 1-617-345-0100 Revenue 3.71B
Industry Chemicals: Specialty Net Income 327.00M
Sector Process Industries Employees 4,064
Fiscal Year-end 09 / 2026
View SEC Filings

CBT Valuation

P/E Current 22.975
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 12.644
Price to Sales Ratio 1.11
Price to Book Ratio 2.593
Price to Cash Flow Ratio 6.20
Enterprise Value to EBITDA 6.675
Enterprise Value to Sales 1.413
Total Debt to Enterprise Value 0.234

CBT Efficiency

Revenue/Employee 913,631.89
Income Per Employee 80,462.598
Receivables Turnover 5.534
Total Asset Turnover 0.983

CBT Liquidity

Current Ratio 1.608
Quick Ratio 1.082
Cash Ratio 0.27

CBT Profitability

Gross Margin 25.478
Operating Margin 17.021
Pretax Margin 15.217
Net Margin 8.807
Return on Assets 8.661
Return on Equity 21.983
Return on Total Capital 11.771
Return on Invested Capital 12.846

CBT Capital Structure

Total Debt to Total Equity 79.226
Total Debt to Total Capital 44.204
Total Debt to Total Assets 32.189
Long-Term Debt to Equity 60.71
Long-Term Debt to Total Capital 33.873
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cabot Corp. - CBT

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
4.32B 3.93B 3.99B 3.71B
Sales Growth
+26.75% -9.03% +1.60% -7.04%
Cost of Goods Sold (COGS) incl D&A
3.44B 3.09B 3.02B 2.77B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
146.00M 144.00M 151.00M 154.00M
Depreciation
140.00M 138.00M 145.00M 148.00M
Amortization of Intangibles
6.00M 6.00M 6.00M 6.00M
COGS Growth
+32.00% -10.01% -2.26% -8.44%
Gross Income
885.00M 839.00M 972.00M 946.00M
Gross Income Growth
+9.80% -5.20% +15.85% -2.67%
Gross Profit Margin
+20.48% +21.34% +24.34% +25.48%
2022 2023 2024 2025 5-year trend
SG&A Expense
313.00M 310.00M 345.00M 314.00M
Research & Development
55.00M 57.00M 63.00M 57.00M
Other SG&A
258.00M 253.00M 282.00M 257.00M
SGA Growth
-0.95% -0.96% +11.29% -8.99%
Other Operating Expense
- - - -
-
Unusual Expense
185.00M 5.00M 15.00M 13.00M
EBIT after Unusual Expense
387.00M 524.00M 612.00M 619.00M
Non Operating Income/Expense
8.00M 21.00M 1.00M 25.00M
Non-Operating Interest Income
11.00M 31.00M 32.00M 27.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
60.00M 94.00M 84.00M 79.00M
Interest Expense Growth
+15.38% +56.67% -10.64% -5.95%
Gross Interest Expense
63.00M 100.00M 93.00M 91.00M
Interest Capitalized
3.00M 6.00M 9.00M 12.00M
Pretax Income
335.00M 451.00M 529.00M 565.00M
Pretax Income Growth
-17.49% +34.63% +17.29% +6.81%
Pretax Margin
+7.75% +11.47% +13.24% +15.22%
Income Tax
102.00M (28.00M) 111.00M 196.00M
Income Tax - Current - Domestic
7.00M 5.00M 14.00M 21.00M
Income Tax - Current - Foreign
135.00M 123.00M 134.00M 143.00M
Income Tax - Deferred - Domestic
2.00M (156.00M) (31.00M) 39.00M
Income Tax - Deferred - Foreign
- (42.00M) (6.00M) (7.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
(3.00M) (8.00M) (6.00M) (4.00M)
Consolidated Net Income
240.00M 476.00M 418.00M 372.00M
Minority Interest Expense
34.00M 39.00M 44.00M 45.00M
Net Income
206.00M 437.00M 374.00M 327.00M
Net Income Growth
-16.60% +112.14% -14.42% -12.57%
Net Margin Growth
+4.77% +11.12% +9.36% +8.81%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
206.00M 437.00M 374.00M 327.00M
Preferred Dividends
- - - 1.00M
-
Net Income Available to Common
206.00M 437.00M 374.00M 326.00M
EPS (Basic)
3.646 7.7897 6.7877 6.0708
EPS (Basic) Growth
-16.31% +113.65% -12.86% -10.56%
Basic Shares Outstanding
56.50M 56.10M 55.10M 53.70M
EPS (Diluted)
3.6204 7.7345 6.7145 6.0148
EPS (Diluted) Growth
-16.75% +113.64% -13.19% -10.42%
Diluted Shares Outstanding
56.90M 56.50M 55.70M 54.20M
EBITDA
718.00M 673.00M 778.00M 786.00M
EBITDA Growth
+10.46% -6.27% +15.60% +1.03%
EBITDA Margin
+16.62% +17.12% +19.48% +21.17%

Snapshot

Average Recommendation HOLD Average Target Price 90.00
Number of Ratings 6 Current Quarters Estimate 1.538
FY Report Date 09 / 2026 Current Year's Estimate 6.361
Last Quarter’s Earnings 1.67 Median PE on CY Estimate N/A
Year Ago Earnings 7.25 Next Fiscal Year Estimate 6.986
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 2 6 6
Mean Estimate 1.54 1.51 6.36 6.99
High Estimates 1.58 1.59 6.42 7.31
Low Estimate 1.49 1.44 6.30 6.70
Coefficient of Variance 1.92 7.10 0.67 3.12

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 3 3 4
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Hold Hold Hold

Insider Actions for Cabot Corp. - CBT

Date Name Shares Transaction Value
Aug 27, 2026 Sean D. Keohane President and CEO; Director 291,652 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $50 per share 14,582,600.00
Aug 27, 2026 Sean D. Keohane President and CEO; Director 288,873 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $85.5 per share 24,698,641.50
Aug 27, 2026 Sean D. Keohane President and CEO; Director 134,895 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 13, 2026 William C. Kirby Director 27,688 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Ying Y. Yan Director 17,171 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Douglas G. Del Grosso Director 15,079 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Juan Enriquez Director 41,526 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Raffiq A. Nathoo Director 926 Conversion of derivative security 0.00
Jan 13, 2026 Raffiq A. Nathoo Director 1,284 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Cynthia A. Arnold Director 19,620 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Frank Anders Wilson Director 18,552 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Thierry F. J. Vanlancker Director 4,902 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Michael M. Morrow Director 22,302 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 13, 2026 Michelle E. Williams Director 6,776 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Cabot Corp. in the News